Quarterly Report • Jul 27, 2022
Quarterly Report
Open in ViewerOpens in native device viewer
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2022
Commission File Number: 001-13742
(Exact name of registrant as specified in its charter)
ICL Group Ltd. Millennium Tower 23 Aranha Street P.O. Box 20245 Tel Aviv, 61202 Israel (972-3) 684-4400 (Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ☐ No ☒
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ☐ No ☒
This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number: 333-205518) of ICL Group Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. In addition, this report on Form 6-K shall be deemed to be incorporated by reference into the Israeli Shelf Prospectus of ICL Group Ltd. filed with the Israel Securities Authority and dated February 28, 2022 (Filing Number: 2022-02-019821) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
ICL GROUP LTD.

Company executed on growth strategy, which continued to result in strong performance of specialties businesses, as it also benefitted from significant market upside
Tel Aviv, Israel, July 27, 2022 – ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2022. Consolidated sales of \$2,880 million were up 78% year-over-year versus \$1,617 million. Operating income of \$1,139 million was up 369% versus \$243 million and up 383% versus adjusted operating income of \$236 million. Net income of \$563 million was up 302%, while adjusted net income of \$751 million was up 456%. Adjusted EBITDA of \$1,258 million was up 249% versus \$360 million. EBITDA margin of 43.7% was up versus 22.3%.
ICL's continued focus on long-term specialties solutions benefitted the Company once again, with additional significant upside from commodity prices. During the quarter, the Company's strong performance was supported by increased demand and higher prices in most markets and achieved despite increased raw material costs and continued global supply chain challenges.
"In the second quarter, ICL delivered all-time record sales, operating income and EBITDA, and another consecutive quarter of profit and margin growth, with record results from all our specialty businesses and our commodity businesses. We also achieved multiple production records, as we continued to focus on efficiency and productivity," said Raviv Zoller, president and CEO of ICL. "Our performance in the quarter reaffirms our specialties strategy, and our strong balance sheet will allow us to accelerate business expansion opportunities, including growth through investments in R&D, capacity and new products, among others."
Due to very strong results in the first half, ICL is raising its expectations for full year adjusted EBITDA to a range of \$3,800 million to \$4,000 million, from previous guidance of \$3,500 million to \$3,750 million. Between \$1,500 million to \$1,600 million of 2022 EBITDA is expected to come from the company's specialties focused businesses, up from previous expectations calling for contribution of \$1,300 million to \$1,400 million. (1a)
In addition, ICL has reached an understanding with the Israeli Tax Authority and settled the dispute concerning the Israeli Law for Taxation of Profits from Natural Resources. The settlement agreement provides final assessments for the tax years 2016 to 2020, as well as outlines understandings for the calculation of the levy for the years from 2021 and onwards. As a result of the settlement agreement, in the second quarter of 2022, the Company recognized tax expenses for prior years in the amount of \$188 million. ICL welcomes the conclusion of this dispute, which ended through a dialogue and prevented the potential for years-long legal proceedings, while providing expected business certainty for years to come.
This Operating and Financial Review and Prospects is based on the Company's unaudited interim condensed consolidated financial statements as of and for the six-month period ended June 30, 2022 (Interim Financial Statements) and is prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board and prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting", unless otherwise stated. The Operating and Financial Review and Prospects contain certain non-IFRS financial measures and forward-looking statements, which are described in the "Financial Figures and non-GAAP Financial Measures" section and the "Forwardlooking Statements" section, respectively.
ICL Group Ltd. is a leading global specialty minerals company that creates impactful solutions for humanity's sustainability challenges in global food, agriculture, and industrial markets. ICL leverages its unique bromine, potash, and phosphate resources, its professional employees, and its strong focus on R&D and technological innovation to drive growth across its end markets. ICL shares are dually listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The Company employs over 12,000 people worldwide, and its 2021 revenues totaled approximately \$7 billion. For more information, visit the Company's website at www.icl-group.com1.
1 The reference to our website is intended to be an inactive textual reference and the information on, or accessible through, our website is not intended to be part of this Form 6-K.
| 4-6/2022 | 4-6/2021 | 1-6/2022 | 1-6/2021 | 1-12/2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| \$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
|
| Sales | 2,880 | - | 1,617 | - | 5,405 | - | 3,127 | - | 6,955 | - |
| Gross profit | 1,539 | 53 | 570 | 35 | 2,784 | 52 | 1,065 | 34 | 2,611 | 38 |
| Operating income | 1,139 | 40 | 243 | 15 | 2,041 | 38 | 428 | 14 | 1,210 | 17 |
| Adjusted operating income (1) | 1,139 | 40 | 236 | 15 | 2,019 | 37 | 421 | 13 | 1,194 | 17 |
| Net income attributable to the shareholders of the Company | 563 | 20 | 140 | 9 | 1,195 | 22 | 275 | 9 | 783 | 11 |
| Adjusted net income - shareholders of the Company (1) | 751 | 26 | 135 | 8 | 1,364 | 25 | 270 | 9 | 824 | 12 |
| Diluted earnings per share (in dollars) | 0.44 | - | 0.11 | - | 0.93 | - | 0.22 | - | 0.60 | - |
| Diluted adjusted earnings per share (in dollars) (2) | 0.58 | - | 0.11 | - | 1.06 | - | 0.21 | - | 0.64 | - |
| Adjusted EBITDA (2) | 1,258 | 44 | 360 | 22 | 2,260 | 42 | 662 | 21 | 1,687 | 24 |
| Cash flows from operating activities | 627 | - | 242 | - | 952 | - | 448 | - | 1,065 | - |
| Purchases of property, plant and equipment and intangible assets (3) |
220 | - | 151 | - | 351 | - | 298 | - | 611 | - |
(1) See "Adjustments to Reported Operating and Net income (non-GAAP)" below.
(2) Commencing 2022, the Company's adjusted EBITDA definition was updated. See the disclaimer below.
(3) See "Condensed consolidated statements of cash flows (unaudited)" in the accompanying financial statements.
We disclose in this quarterly report non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share and adjusted EBITDA. Our management uses adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share and adjusted EBITDA to facilitate operating performance comparisons from period to period. We calculate our adjusted operating income by adjusting our operating income to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating and net income (non-GAAP)" below. Certain of these items may recur. We calculate our adjusted net income attributable to the Company's shareholders by adjusting our net income attributable to the Company's shareholders to add certain items, as set forth in the reconciliation table under "Adjustments to reported operating and net income (non-GAAP)" below, excluding the total tax impact of such adjustments. We calculate our diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. Our adjusted EBITDA is calculated as net income before financing expenses, net, taxes on income, share in earnings of equity-accounted investees, depreciation and amortization, and adjust items presented in the reconciliation table under "Consolidated adjusted EBITDA and diluted adjusted Earnings Per Share for the periods of activity" below, which were adjusted for in calculating the adjusted operating income. Commencing with the year 2022, the Company's "adjusted EBITDA" calculation is no longer adding back "minority and equity income, net". While "minority and equity income, net" reflects the share of an equity investor in one of our owned operations, since adjusted EBITDA measures the Company's performance as a whole, its operations and its ability to satisfy cash needs before profit is allocated to the equity investor, management believes that adjusted EBITDA before deduction of such item is more reflective.
You should not view adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the Company's shareholders determined in accordance with IFRS, and you should note that our definitions of adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of our non-IFRS financial measures as tools for comparison. However, we believe adjusted operating income, adjusted net income attributable to the Company's shareholders, diluted adjusted earnings per share and adjusted EBITDA provide useful information to both management and investors by excluding certain items that management believes are not indicative of our ongoing operations. Our management uses these non-IFRS measures to evaluate the Company's business strategies and management's performance. We believe that these non-IFRS measures provide useful information to investors because they improve the comparability of our financial results between periods and provide for greater transparency of key measures used to evaluate our performance.
(1a) The Company only provides guidance on a non-GAAP basis. The Company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, in particular because special items such as restructuring, litigation and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the Company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material and, therefore, could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. We undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. Specialties focused businesses are represented by the Industrial Products and Innovative Ag Solutions segments and the specialties part of the Phosphate Solutions segment. We present EBITDA from the phosphate specialties part of the Phosphate Solutions segment as we believe this information is useful to investors in reflecting the specialty portion of our business.
We present a discussion in the period-to-period comparisons of the primary drivers of change in the Company's results of operations. This discussion is based in part on management's best estimates of the impact of the main trends on our businesses. We have based the following discussion on our financial statements. You should read such discussion together with our financial statements.
| 4-6/2022 | 4-6/2021 | 1-6/2022 | 1-6/2021 | 1-12/2021 | |
|---|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Operating income | 1,139 | 243 | 2,041 | 428 | 1,210 |
| Divestment related items and transaction costs from acquisitions (1) | - | (8) | (22) | (8) | (22) |
| Dispute and other settlement expenses (2) | - | - | - | - | 5 |
| Impairment and disposal of assets, provision for closure and restoration costs (3) | - | 1 | - | 1 | 1 |
| Total adjustments to operating income | - | (7) | (22) | (7) | (16) |
| Adjusted operating income | 1,139 | 236 | 2,019 | 421 | 1,194 |
| Net income attributable to the shareholders of the Company | 563 | 140 | 1,195 | 275 | 783 |
| Total adjustments to operating income | - | (7) | (22) | (7) | (16) |
| Total tax adjustments (4) | 188 | 2 | 191 | 2 | 57 |
| Total adjusted net income - shareholders of the Company | 751 | 135 | 1,364 | 270 | 824 |
Calculation of adjusted EBITDA was made as follows:
| 4-6/2022 | 4-6/2021 | 1-6/2022 | 1-6/2021 | 1-12/2021 | |
|---|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Net income | 585 | 150 | 1,242 | 292 | 832 |
| Financing expenses, net | 14 | 30 | 48 | 50 | 122 |
| Taxes on income | 540 | 64 | 751 | 87 | 260 |
| Less: Share in earnings of equity-accounted investees | - | (1) | - | (1) | (4) |
| Operating income | 1,139 | 243 | 2,041 | 428 | 1,210 |
| Depreciation and amortization | 119 | 124 | 241 | 241 | 493 |
| Adjustments (1) | - | (7) | (22) | (7) | (16) |
| Total adjusted EBITDA (2) | 1,258 | 360 | 2,260 | 662 | 1,687 |
(1) See "Adjustments to Reported Operating and Net income (non-GAAP)" above.
(2) Commencing 2022, the Company's adjusted EBITDA definition was updated, see the disclaimer above.
Calculation of diluted adjusted earnings per share was made as follows:
| 4-6/2022 | 4-6/2021 | 1-6/2022 | 1-6/2021 | 1-12/2021 | |
|---|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Net income attributable to the shareholders of the Company | 563 | 140 | 1,195 | 275 | 783 |
| Adjustments (1) | - | (7) | (22) | (7) | (16) |
| Total tax adjustments | 188 | 2 | 191 | 2 | 57 |
| Adjusted net income - shareholders of the Company | 751 | 135 | 1,364 | 270 | 824 |
| Weighted-average number of diluted ordinary shares outstanding (in thousands) |
1,291,696 | 1,285,658 | 1,291,243 | 1,284,873 | 1,287,051 |
| Diluted adjusted earnings per share (in dollars) (2) | 0.58 | 0.11 | 1.06 | 0.21 | 0.64 |
(1) See "Adjustments to Reported Operating and Net income (non-GAAP)" above.
(2) The diluted adjusted earnings per share is calculated as follows: dividing the adjusted net income-shareholders of the Company by the weighted-average number of diluted ordinary shares outstanding (in thousands).
The duration of the crisis in Ukraine cannot be predicted and it is difficult to assess its future impact on ICL's results and operations. However, in the Company's estimation, no material adverse effects on its business operations are expected. The Company continuously reviews developments relating to the crisis and its potential consequences and will make necessary adjustments to minimize any negative effects on the results of its activities, as much as possible.
| Sales | Expenses | Operating income | ||
|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | ||
| Q2 2021 figures | 1,617 | (1,374) | 243 | |
| Total adjustments Q2 2021* | - | (7) | (7) | |
| Adjusted Q2 2021 figures | 1,617 | (1,381) | 236 | |
| New Brazilian Business' contribution | 177 | (139) | 38 | |
| Quantity | (12) | (8) | (20) | |
| Price | 1,211 | - | 1,211 | |
| Exchange rates | (113) | 80 | (33) | |
| Raw materials | - | (173) | (173) | |
| Energy | - | (25) | (25) | |
| Transportation | - | (48) | (48) | |
| Operating and other expenses | - | (47) | (47) | |
| Adjusted Q2 2022 figures | 2,880 | (1,741) | 1,139 | |
| Total adjustments Q2 2022* | - | - | - | |
| Q2 2022 figures | 2,880 | (1,741) | 1,139 |
* See "Adjustments to reported Operating and Net income (non-GAAP)" above.
New Brazilian business' contribution - In July 2021, the Company completed the acquisition of a South American plant nutrition business, ADS.
Quantity The negative impact on operating income was primarily related to a decrease in sales volumes of bromine and phosphorus-based flame retardants, phosphate fertilizers, and bromine-based industrial solutions, mainly elemental bromine. This trend was partly offset by higher sales volumes of clear brine fluids, acids and salts, mainly in Asia and Europe.
Energy The negative impact on operating income was due to an increase in electricity prices, mainly in Europe.
Transportation The negative impact on operating income was due to an increase in marine and inland transportation costs.
The following table sets forth sales by geographical regions based on the location of the customers:
| 4-6/2022 | 4-6/2021 | |||||
|---|---|---|---|---|---|---|
| \$ millions | % of Sales | \$ millions | % of Sales | |||
| Asia | 729 | 25 | 462 | 29 | ||
| Europe | 806 | 28 | 519 | 32 | ||
| South America | 828 | 29 | 262 | 16 | ||
| North America | 359 | 12 | 271 | 17 | ||
| Rest of the world | 158 | 6 | 103 | 6 | ||
| Total | 2,880 | 100 | 1,617 | 100 |
Net financing expenses in the second quarter of 2022 amounted to \$14 million compared to \$30 million in the corresponding quarter last year, a decrease of \$16 million.
The main change is due to long-term employee benefits provisions and lease revaluation income, which increased by \$57 million, due to depreciation of the Israeli shekel against the US dollar compared to appreciation in the corresponding quarter. On the other hand, for the same reason, there was an increase of \$38 million in losses from hedging transactions.
In the second quarter of 2022, the Company's reported tax expenses amounted to \$540 million, reflecting, in part, a settlement agreement with the Israeli Tax Authority regarding the surplus profit levy. Following the settlement agreement, the Company recorded tax expenses in respect of prior years in the amount of \$188 million. The quarter's tax expenses, excluding the said prior year's expenses, amounted to \$352 million compared to \$64 million in the corresponding quarter last year, reflecting an effective tax rate of 31% and 30%, respectively. The Company's relatively high effective tax rate for this quarter was the result of tax expenses relating to the surplus profit levy for the current period, partially offset by the favorable impact of the devaluation of the Israeli shekel against the US dollar. The Company's relatively high tax rate in the corresponding quarter was mainly affected by the appreciation of the Israeli shekel against the US dollar, which had a negative effect on the shekel denominated tax provisions.
| Sales | Expenses | Operating income | ||
|---|---|---|---|---|
| \$ millions | ||||
| YTD 2021 figures | 3,127 | (2,699) | 428 | |
| Total adjustments YTD 2021* | - | (7) | (7) | |
| Adjusted YTD 2021 figures | 3,127 | (2,706) | 421 | |
| New Brazilian Business' contribution | 302 | (248) | 54 | |
| Quantity | (25) | 10 | (15) | |
| Price | 2,156 | - | 2,156 | |
| Exchange rates | (155) | 99 | (56) | |
| Raw materials | - | (326) | (326) | |
| Energy | - | (48) | (48) | |
| Transportation | - | (74) | (74) | |
| Operating and other expenses | - | (93) | (93) | |
| Adjusted YTD 2022 figures | 5,405 | (3,386) | 2,019 | |
| Total adjustments YTD 2022* | - | 22 | 22 | |
| YTD 2022 figures | 5,405 | (3,364) | 2,041 |
* See "Adjustments to reported operating and net income (non-GAAP)" above.
Transportation The negative impact on operating income was due to an increase in marine and inland transportation costs.
Operating and other expenses – The negative impact on operating income was primarily related to higher maintenance and operational costs, and royalty payments due to higher revenue.
The following table sets forth sales by geographical regions based on the location of the customers:
| 1-6/2022 | 1-6/2021 | |||
|---|---|---|---|---|
| \$ millions | % of Sales | \$ millions | % of Sales | |
| Asia | 1,466 | 27 | 846 | 27 |
| Europe | 1,530 | 28 | 1,147 | 37 |
| South America | 1,344 | 25 | 371 | 12 |
| North America | 774 | 14 | 566 | 18 |
| Rest of the world | 291 | 6 | 197 | 6 |
| Total | 5,405 | 100 | 3,127 | 100 |
Net financing expenses in the six-month period ended June 30, 2022, amounted to \$48 million, compared to \$50 million in the corresponding period last year, a decrease of \$2 million.
The main change is due to provisions for long-term employee benefits and lease revaluation income, which increased by \$51 million, due to higher depreciation of the Israeli shekel against the US dollar compared to the corresponding period. On the other hand, for the same reason, there was an increase of \$32 million in losses from hedging transactions, as well as \$7 million decrease in capitalized interest income and a \$7 million increase in short-term hedging expenses.
For the six-month period ended June 30, 2022, the Company's reported tax expenses amounted to \$751 million, reflecting a settlement agreement with the Israeli Tax Authority regarding the surplus profit levy. Following the settlement agreement, the Company recorded tax expenses in respect of prior years in the amount of \$188 million. The tax expenses for the period, excluding the said prior years expenses, amounted to \$560 million compared to \$87 million in the corresponding period last year, reflecting an effective tax rate of 28% and 23%, respectively. The Company's relatively high effective tax rate was the result of tax expenses relating to the surplus profit levy for the current period.
The Industrial Products segment produces bromine out of a highly concentrated solution in the Dead Sea, and bromine-based compounds at its facilities in Israel, the Netherlands and China. In addition, the segment produces salts, magnesium chloride, magnesia-based products, phosphorus-based, products, and functional fluids.
| 4-6/2022 | 4-6/2021 | 1-6/2022 | 1-6/2021 | 1-12/2021 | |
|---|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Segment Sales | 486 | 410 | 980 | 808 | 1,617 |
| Sales to external customers | 478 | 406 | 966 | 800 | 1,601 |
| Sales to internal customers | 8 | 4 | 14 | 8 | 16 |
| Segment Operating Income | 191 | 114 | 379 | 219 | 435 |
| Depreciation and amortization | 15 | 14 | 30 | 31 | 65 |
| Segment EBITDA | 206 | 128 | 409 | 250 | 500 |
| Capital expenditures | 18 | 14 | 40 | 31 | 74 |
• Sales of bromine-based flame retardants increased year-over-year mainly due to higher pricing in most market segments, such as electronics, EVs, construction, and textiles. However, electronics demand was softer.
• The segment recorded lower year-over-year sales of elemental bromine, driven by COVID-19 related lockdown restrictions in China.
| Sales | Expenses | Operating income | ||
|---|---|---|---|---|
| \$ millions | ||||
| Q2 2021 figures | 410 | (296) | 114 | |
| Quantity | (47) | 33 | (14) | |
| Price | 135 | - | 135 | |
| Exchange rates | (12) | 7 | (5) | |
| Raw materials | - | (18) | (18) | |
| Energy | - | (1) | (1) | |
| Transportation | - | (8) | (8) | |
| Operating and other expenses | - | (12) | (12) | |
| Q2 2022 figures | 486 | (295) | 191 | |
Quantity – The negative impact on operating income was primarily related to a decrease in sales volumes of bromine and phosphorus-based flame retardants, as well as brominebased industrial solutions, mainly elemental bromine. This decrease was partially offset by a sales volume increase of clear brine fluids.
Price – The positive impact on operating income was due to higher selling prices of bromine and phosphorus-based flame retardants, as well as bromine industrial solutions, mainly elemental bromine.
Exchange rates – The unfavorable impact on operating income was primarily related to depreciation of the average exchange rate of the euro against the US dollar, which led to a negative impact on sales that exceeded the positive impact on operational costs.
Raw materials – The negative impact on operating income was primarily due to an increase in prices of raw materials used in the production of phosphorus-based flame retardants.
Transportation - The negative impact on operating income primarily resulted from higher marine transportation costs.
Operating and other expenses – The negative impact on operating income was primarily related to higher operational costs and royalties payments due to higher revenue.
| Sales | Expenses | Operating income | ||
|---|---|---|---|---|
| \$ millions | ||||
| YTD 2021 figures | 808 | (589) | 219 | |
| Quantity | (94) | 66 | (28) | |
| Price | 285 | - | 285 | |
| Exchange rates | (19) | 8 | (11) | |
| Raw materials | - | (44) | (44) | |
| Energy | - | (4) | (4) | |
| Transportation | - | (16) | (16) | |
| Operating and other expenses | - | (22) | (22) | |
| YTD 2022 figures | 980 | (601) | 379 |
Quantity – The negative impact on operating income was primarily related to a decrease in sales volumes of bromine and phosphorus-based flame retardants, as well as brominebased industrial solutions, mainly elemental bromine and clear brine fluids.
Price – The positive impact on operating income was due to higher selling prices of bromine and phosphorus-based flame retardants, as well as bromine industrial solutions, mainly elemental bromine.
Exchange rates – The unfavorable impact on operating income was primarily related to the depreciation of the average exchange rate of the euro against the US dollar, which led to a negative impact on sales that exceeded the positive impact on operational costs.
Raw materials The negative impact on the segment's operating income was primarily related to higher prices of raw materials used in production of bromine- and phosphorus-based flame retardants.
Transportation The negative impact on the segment's operating income was primarily related to higher marine transportation costs.
Operating and other expenses – The negative impact on operating income was primarily related to higher operational costs and royalties payments due to higher revenues.
The Potash segment produces and sells mainly potash, salts, magnesium, and electricity. Potash is produced in Israel and Spain using an evaporation process to extract potash from the Dead Sea in Israel and conventional mining from an underground mine in Spain. The segment also includes the production and sale of pure magnesium and magnesium alloys, as well as the production and sale of chlorine. In addition, the segment sells salt products produced at its potash site in Spain. The segment operates a power plant in Sodom, which supplies electricity to ICL companies in Israel (surplus electricity is sold to external customers) and steam to all facilities at the Sodom site.
| 4-6/2022 | 4-6/2021 | 1-6/2022 | 1-6/2021 | 1-12/2021 | |
|---|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Segment Sales | 951 | 380 | 1,746 | 729 | 1,776 |
| Potash sales to external customers | 810 | 296 | 1,458 | 550 | 1,401 |
| Potash sales to internal customers | 50 | 27 | 93 | 49 | 94 |
| Other and eliminations (1) | 91 | 57 | 195 | 130 | 281 |
| Gross Profit | 698 | 154 | 1,221 | 289 | 870 |
| Segment Operating Income | 576 | 42 | 986 | 71 | 399 |
| Depreciation and amortization | 40 | 38 | 80 | 71 | 148 |
| Segment EBITDA | 616 | 80 | 1,066 | 142 | 547 |
| Capital expenditures | 113 | 68 | 175 | 127 | 270 |
| Average realized price (in \$) (2) | 750 | 281 | 675 | 269 | 337 |
(1) Primarily includes salt produced in Spain, metal magnesium-based products, chlorine and sales of excess electricity produced by ICL's power plants at the Dead Sea in Israel.
(2) The average realized price (dollar per ton) of potash is calculated by dividing total potash revenue by total sales quantities. The difference between the Free on Board (FOB) price and the average realized price is primarily due to marine transportation costs, local market (Israel) sales and internal consumption sales.
• Potash prices continued to rise globally during the beginning of the second quarter. This trend continued in Asia toward the end of the quarter due to tight supply, including in China, which continued its imports from Laos via a new cross-border rail line, but also from Belarus despite the related sanctions imposed by the US, EU, UK and Canada. In contrast, in the US and Brazil the above trend reversed toward the end of the second quarter due to decreasing demand in parallel with declining soybean prices, as described above, supported by availability of imports from Russia, despite the war with Ukraine, leading to a significant buildup of stocks in Brazil. For additional information on potash prices and imports in key markets, see the "Global potash market - average prices and imports" table below.
• In June 2022, unexpected flow of brine was discovered above ground at the outskirts of an alluvial fan area, which according to initial tests by the Company, appear to have resulted from a combination of seepage from a certain area of the feeder canal of ICL Dead Sea's pumping station P-9 (hereinafter P-9), which according to the Company's estimations does not exceed the approved design specifications of P-9, and unique ground conditions. The Company has acted, and is continuously acting, to explore solutions for the short and long term and to rectify any environmental impacts caused to the extent required. For further information please see note 6 to the Company's interim Financial Statements.
• Operational challenges and geological challenges at ICL Iberia's mine negatively impacted production during the second quarter. ICL Iberia has initiated performance improvement measurements, which are expected to increase production during the second half of the year. In addition, a ramp-up at the sites flotation plant is planned for the third quarter. These actions will enable ICL Iberia to reach and sustain a one-million-ton production level while lowering its cost per ton.
• Metal Magnesium sales increased year-over-year due to annual contracts secured at higher prices following continuous recovery of demand in global end-markets.
Global potash market - average prices and imports:
| Average prices | 04-06/2022 | 04-06/2021 | VS Q2 2021 | 01-03/2022 | VS Q1 2022 | |
|---|---|---|---|---|---|---|
| Granular potash – Brazil | CFR spot (\$ per ton) |
1,115 | 383 | 191.1% | 877 | 27.1% |
| Granular potash – Northwest Europe |
CIF spot/contract (€ per ton) |
869 | 256 | 239.5% | 618 | 40.6% |
| Standard potash – Southeast Asia | CFR spot (\$ per ton) |
929 | 281 | 230.6% | 656 | 41.6% |
| Potash imports | ||||||
| To Brazil | million tons | 3.6 | 3 | 20.0% | 3.1 | 16.1% |
| To China | million tons | 2 | 2 | - | 2.1 | (4.8)% |
| To India | million tons | 0.55 | 0.59 | (6.8)% | 0.72 | (23.6)% |
Sources: CRU (Fertilizer Week Historical Price: July 2022), FAI, Brazilian and Chinese customs data.
| Thousands of tons | 4-6/2022 | 4-6/2021 | 1-6/2022 | 1-6/2021 | 1-12/2021 |
|---|---|---|---|---|---|
| Production | 1,211 | 1,022 | 2,304 | 2,174 | 4,514 |
| Total sales (including internal sales) | 1,147 | 1,148 | 2,297 | 2,223 | 4,434 |
| Closing inventory | 362 | 226 | 362 | 226 | 355 |
| Sales | Expenses | Operating income | ||
|---|---|---|---|---|
| \$ millions | ||||
| Q2 2021 figures | 380 | (338) | 42 | |
| Quantity | (4) | - | (4) | |
| Price | 603 | - | 603 | |
| Exchange rates | (28) | 11 | (17) | |
| Raw materials | (4) | (4) | ||
| Energy | - | (14) | (14) | |
| Transportation | - | (12) | (12) | |
| Operating and other expenses | - | (18) | (18) | |
| Q2 2022 figures | 951 | (375) | 576 |
Quantity – The negative impact on operating income was primarily related to a decrease in sales volumes of potash from the ICL Dead Sea site.
Price – The positive impact on operating income resulted primarily from an increase of \$469 in the average realized price per ton of potash year-over-year.
Exchange rates – The unfavorable impact on operating income was primarily related to the depreciation of the euro against the US dollar, which led to a negative impact on sales that exceeded the positive impact on operational costs.
Energy - The negative impact on operating income was due to an increase in electricity and gas prices, mainly in Europe.
Transportation – The negative impact on operating income resulted primarily from an increase in marine and inland transportation costs.
Operating and other expenses - The negative impact on operating income was primarily related to higher operational costs and royalty payments due to higher revenues.
| Sales | Expenses | Operating income | ||
|---|---|---|---|---|
| \$ millions | ||||
| YTD 2021 figures | 729 | (658) | 71 | |
| Quantity | 13 | (15) | (2) | |
| Price | 1,044 | - | 1,044 | |
| Exchange rates | (40) | 13 | (27) | |
| Raw materials | (4) | (4) | ||
| Energy | - | (26) | (26) | |
| Transportation | - | (21) | (21) | |
| Operating and other expenses | - | (49) | (49) | |
| YTD 2022 figures | 1,746 | (760) | 986 |
Quantity – The minor negative impact on operating income was primarily related to a decrease in sales volumes of potash from the ICL Dead Sea site.
Price – The positive impact on operating income resulted primarily from an increase of \$406 in the average realized price per ton of potash year-over-year.
Exchange rates – The unfavorable impact on operating income was primarily related to the depreciation of the euro against the US dollar, which led to a negative impact on sales that exceeded the positive impact on operational costs.
Energy - The negative impact on operating income was due to an increase in electricity and gas prices, mainly in Europe.
Transportation – The negative impact on operating income resulted primarily from an increase in marine and inland transportation costs.
Operating and other expenses – The negative impact on operating income was primarily related to higher operational costs and royalty payments due to higher revenues.
The Phosphate Solutions segment operates ICL's phosphate value chain and uses phosphate rock and fertilizer-grade phosphoric acid to produce phosphate-based specialty products with higher added value, as well as to produce and sell phosphate-based fertilizers.
Phosphate specialties sales of \$493 million and operating income of \$117 million in the second quarter of 2022, were approximately 50% and 216% higher, respectively, compared to the second quarter of 2021. The increase in operating income was driven mainly by strong sales volumes and higher prices, which offset increased raw material prices and production costs. Despite ongoing supply chain challenges, the segment's global production footprint enabled it to provide reliable supply to its customers worldwide.
Sales of phosphate commodities amounted to \$422 million, approximately 67% higher than the second quarter of 2021, mostly due to a significant increase in market prices. Operating income of \$151 million, a year-over-year increase of \$111 million, was mostly due to higher prices and strong results from YPH, partially offset by higher costs of raw materials, mainly sulphur.
| 4-6/2022 | 4-6/2021 | 1-6/2022 | 1-6/2021 | 1-12/2021 | |
|---|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Segment Sales | 915 | 582 | 1,713 | 1,084 | 2,254 |
| Sales to external customers | 832 | 539 | 1,580 | 1,006 | 2,087 |
| Sales to internal customers | 83 | 43 | 133 | 78 | 167 |
| Segment Operating Income | 268 | 77 | 468 | 119 | 294 |
| Depreciation and amortization* | 47 | 56 | 94 | 108 | 207 |
| Segment EBITDA | 315 | 133 | 562 | 227 | 501 |
| Capital expenditures | 60 | 67 | 109 | 115 | 228 |
* For Q2 2022, comprised of \$14 million in phosphate specialties and \$33 million in phosphate commodities. For Q2 2021, \$13 million in phosphate specialties and \$43 million in phosphate commodities.
Sale of dairy proteins increased substantially year-over-year driven by strong demand for the segment's specialty milk powders, including an innovative milk protein which provides for better taste and texture in Greek yogurt and other food applications.
Phosphate fertilizer prices continued to increase in the second quarter, compared to the previous quarter, but moderated somewhat toward the end of the quarter due to increased supply and lower crop prices. Increased supply was attributed to the renewal of China's exports following a relief in government ban on exports, the continuation of exports from Russia, and the cancellation by Turkey of its DAP exports ban. Trends in the global DAP/MAP markets include:
Global phosphate commodities market - average prices:
| Average prices | \$ per ton | 04-06/2022 | 04-06/2021 | VS Q2 2021 | 01-03/2022 | VS Q1 2022 |
|---|---|---|---|---|---|---|
| DAP | CFR India Bulk Spot | 955 | 565 | 69% | 940 | 2% |
| TSP | CFR Brazil Bulk Spot | 1034 | 527 | 96% | 813 | 27% |
| SSP | CFR Brazil inland 18-20% P2O5 Bulk Spot | 602 | 250 | 141% | 435 | 38% |
| Sulphur | Bulk FOB Adnoc monthly Bulk contract | 455 | 185 | 146% | 325 | 40% |
Source: CRU (Fertilizer Week Historical Prices, July 2022).
| Sales | Expenses | Operating income | |
|---|---|---|---|
| \$ millions | |||
| 582 | (505) | 77 | |
| 55 | (44) | 11 | |
| 315 | - | 315 | |
| (37) | 27 | (10) | |
| - | (114) | (114) | |
| - | (2) | (2) | |
| - | (7) | (7) | |
| - | (2) | (2) | |
| 915 | (647) | 268 | |
Quantity – The positive impact on operating income was primarily related to strong sales volumes of acids and salts, mainly in Asia and Europe. This trend was partly offset by a decrease in sales volumes of phosphate fertilizers.
Price – The positive impact on operating income was primarily related to an increase in the selling prices of phosphate fertilizers, acids, salts, and phosphate-based food additives.
Exchange rates The unfavorable impact on operating income was primarily related to the depreciation of the average exchange rate of the euro and the average exchange rate of the Chinese yuan against the US dollar, which led to a negative impact on sales that exceeded the positive impact on operational costs.
| Sales | Expenses | Operating income | ||
|---|---|---|---|---|
| \$ millions | ||||
| YTD 2021 figures | 1,084 | (965) | 119 | |
| Quantity | 134 | (92) | 42 | |
| Price | 544 | - | 544 | |
| Exchange rates | (49) | 35 | (14) | |
| Raw materials | - | (201) | (201) | |
| Energy | - | (4) | (4) | |
| Transportation | - | (11) | (11) | |
| Operating and other expenses | - | (7) | (7) | |
| YTD 2022 figures | 1,713 | (1,245) | 468 |
Quantity – The positive impact on operating income was driven mainly by strong sales volumes of acids, salts, phosphate fertilizers, and phosphate-based food additives.
Price – The positive impact on operating income was primarily related to an increase in the selling prices of phosphate fertilizers, acids, salts, and phosphate-based food additives.
Exchange rates – The unfavorable impact on operating income was primarily related to the depreciation of the average exchange rate of the euro against the US dollar, which led to a negative impact on sales that exceeded the positive impact on operational costs.
Raw materials – The negative impact on operating income was due to higher prices of sulphur consumed during the quarter.
Transportation The negative impact on operating income resulted primarily from an increase in marine and inland transportation costs.
The Innovative Ag Solutions segment aims to achieve global leadership in specialty fertilizers markets by enhancing its position in its core markets of specialty agriculture, ornamental horticulture, turf and landscaping, fertilizers and FertilizerpluS, targeting high-growth markets such as Brazil, India, and China. The segment also looks to leverage its unique R&D capabilities, substantial agronomic experience, global footprint, backward integration to potash, phosphate, polysulphate and its chemistry know-how, as well as its ability to integrate and generate synergies from acquired businesses. ICL works continuously to expand its broad portfolio of specialty plant nutrition, plant stimulation and plant health solutions, which consist of enhanced efficiency and controlled release fertilizers (CRF), water-soluble fertilizers (WSF), liquid fertilizers and straights (MKP/MAP/PeKacid), the FertilizerpluS range, soil and foliar micronutrients, secondary nutrients, biostimulants, soil conditioners, seed treatment products, and adjuvants.
As the Company continues to focus on targeting long-term growth through its diversified specialty solutions, it decided to change its managerial structure so that, as of January 2022, the activities of ICL Boulby and other European business components were allocated from the potash and phosphate solutions segments, respectively, to the Innovative Ag Solutions segment. Comparative figures have been restated to reflect the structural change of the reportable segments.
| 4-6/2022 | 4-6/2021 | 1-6/2022 | 1-6/2021 | 1-12/2021 | |
|---|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Segment Sales | 700 | 334 | 1,266 | 674 | 1,670 |
| Sales to external customers | 689 | 331 | 1,245 | 668 | 1,644 |
| Sales to internal customers | 11 | 3 | 21 | 6 | 26 |
| Segment Operating Income | 141 | 21 | 234 | 41 | 135 |
| Depreciation and amortization | 14 | 13 | 31 | 26 | 62 |
| Segment EBITDA | 155 | 34 | 265 | 67 | 197 |
| Capital expenditures | 21 | 10 | 38 | *23 | *74 |
* Not including capital expenditures as part of the business combination. For further information, see Note 3 to the Company's Interim Financial Statements.
Sales of the Turf and Ornamental business (T&O) increased year-over-year mainly due to higher selling prices.
Sales of Fertilizerplus (the Company's Polysulphate line of products) increased year-over-year due to higher selling prices and sales volumes.
ICL Boulby
• In the second quarter of 2022, the production of Polysulphate increased by 20% year-over-year to 246 thousand tons.
| Sales | Expenses | Operating income | ||
|---|---|---|---|---|
| \$ millions | ||||
| Q2 2021 figures | 334 | (313) | 21 | |
| New Brazilian Business' contribution | 177 | (139) | 38 | |
| Quantity | 10 | (8) | 2 | |
| Price | 215 | - | 215 | |
| Exchange rates | (36) | 31 | (5) | |
| Raw materials | - | (90) | (90) | |
| Energy | - | (7) | (7) | |
| Transportation | - | (21) | (21) | |
| Operating and other expenses | - | (12) | (12) | |
| Q2 2022 figures | 700 | (559) | 141 |
New Brazilian business' contribution - In July 2021, the Company completed its acquisition of the South American plant nutrition business of Compass Minerals América do Sul S.A. (hereinafter - ADS).
Quantity – The positive impact on operating income was due to higher sales volumes of FertilizerpluS products.
Price – The positive impact on operating income was due to higher selling prices across most business lines, primarily specialty agriculture and FertilizerpluS products.
Exchange rates The unfavorable impact on operating income was primarily related to the depreciation of the average exchange rate of the euro against the US dollar, which led to a negative impact on sales that exceeded the positive impact on operational costs.
| Sales | Expenses | Operating income | ||
|---|---|---|---|---|
| \$ millions | ||||
| YTD 2021 figures | 674 | (633) | 41 | |
| New Brazilian Business' contribution | 302 | (248) | 54 | |
| Quantity | (22) | 15 | (7) | |
| Price | 360 | - | 360 | |
| Exchange rates | (48) | 42 | (6) | |
| Raw materials | - | (149) | (149) | |
| Energy | - | (15) | (15) | |
| Transportation | - | (26) | (26) | |
| Operating and other expenses | - | (18) | (18) | |
| YTD 2022 figures | 1,266 | (1,032) | 234 |
New Brazilian businesses' contribution – In July 2021, the company completed the acquisition of the South American Plant Nutrition business of Compass Minerals América do Sul S.A. (hereinafter - ADS).
Quantity – The negative impact on operating income was due to lower sales volumes of specialty agriculture. This trend was partially offset by an increase in sales volumes of FertilizerpluS products.
Price – The positive impact on operating income was due to higher selling prices across most business lines, primarily specialty agriculture and FertilizerpluS products.
Exchange rate –The unfavorable impact on operating income was primarily related to the depreciation of the average exchange rate of the euro against the US dollar, which led to a negative impact on sales that exceeded the positive impact on operational costs.
In the second quarter of 2022, cash flow provided by operating activities amounted to \$627 million, compared to \$242 million in the corresponding quarter last year. The increase was mainly due to stronger operating results in the current quarter.
In the second quarter of 2022, net cash used in investing activities amounted to \$264 million compared to \$58 million in the corresponding quarter last year. The increase was mainly due to higher investment in property, plant and equipment and the settlement of the earn-out payment relating to the acquisition of ADS.
In the second quarter of 2022, net cash used in financing activities amounted to \$351 million, compared to \$31 million in the corresponding quarter last year. The increase was mainly due to higher dividend payments and higher repayment of long-term debt in the current quarter.
As of June 30, 2022, ICL's net financial liabilities amounted to \$2,241 million, a decrease of \$208 million compared to December 31, 2021.
The total amount of the Company's securitization facility framework is \$300 million. As of June 30, 2022, ICL has utilized approximately \$179 million of the facility's framework.
ICL has long-term credit facilities of \$1,200 million, of which \$291 million were utilized as of June 30, 2022. Subsequent to the date of the report, in July 2022, the long-term credit facility decreased by \$100 million following agreement on an early termination of one of the banks a few months prior to its official termination date. The updated total credit facility is \$1,100 million.
In April 2022, the Company prepaid its MUFG credit facility loan of BRL180 million and terminated its BRL 230 million (about \$48 million) credit facility in Brazil.
In June 2022, Fitch Ratings reaffirmed the Company's long-term issuer default rating and senior unsecured rating at 'BBB-'. The outlook on the long-term issuer default rating is stable.
As of July 5, 2022, the S&P credit rating agency reaffirmed the Company's international credit rating and senior unsecured rating of 'BBB-'. In addition, the S&P Maalot credit rating agency reaffirmed the Company's credit rating of 'ilAA' with a stable rating outlook.
As of June 30, 2022, the Company was in compliance with all of its financial covenants stipulated in its financing agreements.
In the six and three month period ended June 30, 2022, there were no material changes in the critical accounting estimates previously disclosed in our Annual Report on Form 20-F for the year ended December 31, 2021.
In March 2022, a temporary amendment to the Israeli Companies Regulations (Rules regarding Compensation and Expenses to an External Director) was published, allowing the boards of directors to adopt criteria for reclassification for compensation purposes, of participation of directors in meetings held electronically, as physical participation in meetings, during the period of a health condition was declared due to COVID-19. Accordingly, on May 25, 2022, the Company's Board of Directors adopted the criteria. Following implementation of the criteria, the Company paid the relevant directors additional compensation of approximately NIS 202 thousand.
On June 29, 2022, further to the recommendation of an appointment committee comprised of independent and non-independent board members, the Company's Board of Directors appointed Ms. Michal Silverberg to serve as a director of the Company, effective as of July 1, 2022, until the next annual general meeting of shareholders of the Company.
In the six and three month period ended June 30, 2022, there were no material changes in the risk factors previously disclosed in our Annual Report on Form 20-F for the year ended December 31, 2021.
Reference is made to "Item 11 – Quantitative and Qualitative Disclosures about Market Risks" in our Annual Report on Form 20-F for the year ended December 31, 2021.
For information regarding legal proceedings and other contingencies, see Note 6 to the Company's Interim Financial Statements.
This announcement contains statements that constitute "forwardlooking statements", many of which can be identified by the use of forwardlooking words such as "anticipate", "believe", "could", "expect", "should", "plan", "intend", "estimate", "strive", "forecast", "targets" and "potential", among others.
Forwardlooking statements appear in a number of places in this announcement and include, but are not limited to, statements regarding our intent, belief or current expectations. Forwardlooking statements are based on our management's beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forwardlooking statements due to various factors, including, but not limited to:
Changes in exchange rates or prices compared to those we are currently experiencing; loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and our reserve estimates; natural disasters; failure to "harvest" salt which could lead to accumulation of salt at the bottom of the evaporation Pond 5 in the Dead Sea; construction of a new pumping station; disruptions at our seaport shipping facilities or regulatory restrictions affecting our ability to export our products overseas; general market, political or economic conditions in the countries in which we operate; price increases or shortages with respect to our principal raw materials; delays in the completion of major projects by third party contractors and/or termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea could adversely affect production at our plants; labor disputes, slowdowns and strikes involving our employees; pension and health insurance liabilities; the ongoing COVID-19 pandemic, which has impacted, and may continue to impact our sales, operating results and business operations by disrupting our ability to purchase raw materials, by negatively impacting the demand and pricing for some of our products, by disrupting our ability to sell and/or distribute products, impacting customers' ability to pay us for past or future purchases and/or temporarily closing our facilities or the facilities of our suppliers or customers and their contract manufacturers, or restricting our ability to travel to support our sites or our customers around the world; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; changes in our evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; higher tax liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of our, or our service providers', information technology systems or breaches of our, or our service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from our cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of our businesses; changes in demand for our fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond our control; sales of our magnesium products being affected by various factors that are not within our control; our ability to secure approvals and permits from the authorities in Israel to continue our phosphate mining operations in Rotem Amfert Israel; volatility or crises in the financial markets; uncertainties surrounding the withdrawal of the United Kingdom from the European Union; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of our workers and processes; cost of compliance with environmental regulatory legislative and licensing restrictions; laws and regulation related to, and physical impacts of climate change and greenhouse gas emissions; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and foodborne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; filing of class actions and derivative actions against the Company, its executives and Board members; The Company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under "Item 3 - Key Information— D. Risk Factors" in the Company's Annual Report on Form 20-F for the year ended December 31, 2021, filed with the U.S. Securities and Exchange Commission (the "SEC") on February 23, 2022 (the "Annual Report").
Forwardlooking statements speak only as of the date they are made, and we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.
This report for the second quarter of 2022 (the "Quarterly Report") should be read in conjunction with the Annual Report and the report for the first quarter of 2022 published by the Company (the "prior quarterly report"), including the description of events occurring subsequent to the date of the statement of financial position, as filed with the US SEC.
As of June 30, 2022 in Millions of US Dollars

| June 30, 2022 |
June 30, 2021 |
December 31, 2021 |
||
|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | ||
| Current assets | ||||
| Cash and cash equivalents | 426 | 318 | 473 | |
| Short-term investments and deposits | 90 | 92 | 91 | |
| Trade receivables | 1,812 | 1,097 | 1,418 | |
| Inventories | 1,857 | 1,207 | 1,570 | |
| Prepaid expenses and other receivables | 572 | 524 | 357 | |
| Total current assets | 4,757 | 3,238 | 3,909 | |
| Non-current assets | ||||
| Deferred tax assets | 132 | 143 | 147 | |
| Property, plant and equipment | 5,749 | 5,601 | 5,754 | |
| Intangible assets | 867 | 725 | 867 | |
| Other non-current assets | 273 | 373 | 403 | |
| Total non-current assets | 7,021 | 6,842 | 7,171 | |
| Total assets | 11,778 | 10,080 | 11,080 | |
| Current liabilities | ||||
| Short-term debt Trade payables |
466 1,132 |
630 801 |
577 1,064 |
|
| Provisions | 53 | 55 | 59 | |
| Other payables | 1,227 | 659 | 912 | |
| Total current liabilities | 2,878 | 2,145 | 2,612 | |
| Non-current liabilities | ||||
| Long-term debt and debentures | 2,291 | 2,212 | 2,436 | |
| Deferred tax liabilities | 450 | 368 | 384 | |
| Long-term employee liabilities Long-term provisions and accruals |
435 266 |
622 278 |
564 278 |
|
| 62 | 76 | 70 | ||
| Other Total non-current liabilities |
3,504 | 3,556 | 3,732 | |
| Total liabilities | 6,382 | 5,701 | 6,344 | |
| Equity | ||||
| Total shareholders' equity | 5,153 | 4,201 | 4,527 | |
| Non-controlling interests | 243 | 178 | 209 | |
| Total equity | 5,396 | 4,379 | 4,736 | |
| Total liabilities and equity | 11,778 | 10,080 | 11,080 | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
(In millions except per share data)
| June 30, 2022 June 30, 2021 June 30, 2022 June 30, 2021 |
December 31, 2021 |
|---|---|
| \$ millions \$ millions \$ millions \$ millions |
\$ millions |
| Sales 2,880 5,405 1,617 3,127 |
6,955 |
| 1,341 1,047 2,621 2,062 Cost of sales |
4,344 |
| Gross profit 1,539 570 2,784 1,065 |
2,611 |
| Selling, transport and marketing expenses 321 246 600 475 |
1,067 |
| General and administrative expenses 74 67 143 129 |
276 |
| Research and development expenses 17 14 35 29 |
64 |
| Other expenses 6 25 6 30 |
57 |
| (18) (25) (41) (26) Other income |
(63) |
| 1,139 243 2,041 428 Operating income |
1,210 |
| Finance expenses 138 64 205 62 |
216 |
| (124) (34) (157) (12) Finance income |
(94) |
| Finance expenses, net 14 48 30 50 |
122 |
| 1 1 - - Share in earnings of equity-accounted investees |
4 |
| Income before taxes on income 1,125 214 1,993 379 |
1,092 |
| 540 751 64 87 Taxes on income |
260 |
| 585 150 1,242 292 Net income |
832 |
| 22 10 47 17 Net income attributable to the non-controlling interests |
49 |
| 563 1,195 140 275 Net income attributable to the shareholders of the Company |
783 |
| Earnings per share attributable to the shareholders of the Company: |
|
| 0.44 0.11 0.93 0.22 Basic earnings per share (in dollars) |
0.61 |
| 0.44 0.93 0.11 0.22 Diluted earnings per share (in dollars) |
0.60 |
| Weighted-average number of ordinary shares outstanding: | |
| 1,286,380 1,281,977 1,286,097 1,281,192 Basic (in thousands) |
1,282,807 |
| Diluted (in thousands) 1,291,696 1,291,243 1,285,658 1,284,873 |
1,287,051 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| For the three-month period ended | For the six-month period ended | For the year ended | |||
|---|---|---|---|---|---|
| June 30, 2022 | June 30, 2021 | June 30, 2022 | June 30, 2021 | December 31, 2021 | |
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | |
| Net income | 585 | 150 | 1,242 | 292 | 832 |
| Components of other comprehensive income that will be reclassified subsequently to net income |
|||||
| Foreign currency translation differences | (194) | 46 | (137) | (18) | (105) |
| Change in fair value of cash flow hedges transferred to the statement of income | 59 | (13) | 76 | 16 | (15) |
| Effective portion of the change in fair value of cash flow hedges | (90) | 11 | (109) | (26) | 13 |
| Tax relating to items that will be reclassified subsequently to net income | 7 | - | 8 | 2 | - |
| (218) | 44 | (162) | (26) | (107) | |
| Components of other comprehensive income that will not be reclassified to net income |
|||||
| Net changes of investments at fair value through other comprehensive income | - | 91 | - | 119 | 155 |
| Actuarial gains from defined benefit plans | 18 | 8 | 60 | 18 | 85 |
| Tax relating to items that will not be reclassified to net income | (3) | (13) | (10) | (15) | (44) |
| 15 | 86 | 50 | 122 | 196 | |
| Total comprehensive income | 382 | 280 | 1,130 | 388 | 921 |
| Comprehensive income attributable to the non-controlling interests | 9 | 14 | 34 | 20 | 54 |
| Comprehensive income attributable to the shareholders of the Company |
373 | 266 | 1,096 | 368 | 867 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| For the three-month period ended | For the six-month period ended | For the year ended | ||||
|---|---|---|---|---|---|---|
| June 30, 2022 | June 30, 2021 | June 30, 2022 | June 30, 2021 | December 31, 2021 | ||
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | ||
| Cash flows from operating activities | ||||||
| Net income | 585 | 150 | 1,242 | 292 | 832 | |
| Adjustments for: | ||||||
| Depreciation and amortization | 119 | 124 | 241 | 241 | 490 | |
| Reversal of fixed assets impairment | - | (9) | - | (9) | (6) | |
| Exchange rate, interest and derivative, net | 75 | - | 116 | 53 | 99 | |
| Tax expenses | 540 | 64 | 751 | 87 | 260 | |
| Change in provisions | (41) | 12 | (59) | (9) | (4) | |
| Other | 6 | 8 | (14) | 10 | (21) | |
| 699 | 199 | 1,035 | 373 | 818 | ||
| Change in inventories | (208) | (3) | (295) | 27 | (267) | |
| Change in trade receivables | 21 | (27) | (448) | (174) | (426) | |
| Change in trade payables | 105 | 36 | 99 | 75 | 274 | |
| Change in other receivables | (89) | (31) | (90) | (40) | 9 | |
| Change in other payables | (52) | (17) | (9) | (29) | 107 | |
| Net change in operating assets and liabilities | (223) | (42) | (743) | (141) | (303) | |
| Interest paid, net | (39) | (37) | (55) | (55) | (89) | |
| Income taxes paid, net of refund | (395) | (28) | (527) | (21) | (193) | |
| Net cash provided by operating activities | 627 | 242 | 952 | 448 | 1,065 | |
| Cash flows from investing activities | ||||||
| Proceeds (payments) from deposits, net | (30) | 90 | (38) | 98 | 355 | |
| Business combinations | (18) | - | (18) | (64) | (365) | |
| Purchases of property, plant and equipment and intangible assets | (220) | (151) | (351) | (298) | (611) | |
| Proceeds from divestiture of assets and businesses, net of transaction expenses | 2 | 1 | 22 | 1 | 39 | |
| Other | 2 | 2 | 14 | 2 | 3 | |
| Net cash used in investing activities | (264) | (58) | (371) | (261) | (579) | |
| Cash flows from financing activities | ||||||
| Dividends paid to the Company's shareholders | (307) | (67) | (476) | (101) | (276) | |
| Receipt of long-term debt | 190 | 187 | 533 | 497 | 1,230 | |
| Repayments of long-term debt | (259) | (144) | (615) | (455) | (1,120) | |
| Receipts (repayments) of short-term debt, net | 25 | 25 | (72) | (16) | (58) | |
| Receipts (payments) from transactions in derivatives | - | (32) | 19 | (18) | (17) | |
| Other | - | - | - | - | (3) | |
| Net cash used in financing activities | (351) | (31) | (611) | (93) | (244) | |
| Net change in cash and cash equivalents | 12 | 153 | (30) | 94 | 242 | |
| Cash and cash equivalents as of the beginning of the period | 439 | 157 | 473 | 214 | 214 | |
| Net effect of currency translation on cash and cash equivalents | (25) | 8 | (17) | 10 | 17 | |
| Cash and cash equivalents as of the end of the period | 426 | 318 | 426 | 318 | 473 | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| Attributable to the shareholders of the Company | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Cumulative translation adjustments |
Capital reserves |
Treasury shares, at cost |
Retained earnings |
Total shareholders' equity |
||||
| \$ millions | ||||||||||
| For the three-month period ended June 30, 2022 |
||||||||||
| Balance as of April 1, 2022 | 548 | 225 | (387) | 138 | (260) | 4,819 | 5,083 | 234 | 5,317 | |
| Share-based compensation | - | 2 | - | 2 | - | - | 4 | - | 4 | |
| Dividends | - | - | - | - | - | (307) | (307) | - | (307) | |
| Comprehensive income | - | - | (181) | (24) | - | 578 | 373 | 9 | 382 | |
| Balance as of June 30, 2022 | 548 | 227 | (568) | 116 | (260) | 5,090 | 5,153 | 243 | 5,396 |
| Non controlling interests |
Total equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Cumulative translation adjustments |
Capital reserves |
Treasury shares, at cost |
Retained earnings |
Total shareholders' equity |
|||
| \$ millions | |||||||||
| For the three-month period ended June 30, 2021 |
|||||||||
| Balance as of April 1, 2021 | 546 | 207 | (397) | 43 | (260) | 3,861 | 4,000 | 164 | 4,164 |
| Share-based compensation | 1 | 10 | - | (9) | - | - | 2 | - | 2 |
| Dividends | - | - | - | - | - | (67) | (67) | - | (67) |
| Comprehensive Income | - | - | 42 | 77 | - | 147 | 266 | 14 | 280 |
| Balance as of June 30, 2021 | 547 | 217 | (355) | 111 | (260) | 3,941 | 4,201 | 178 | 4,379 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
| Non controlling interests |
Total equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Cumulative translation adjustments |
Capital reserves |
Treasury shares, at cost |
Retained earnings |
Total shareholders' equity |
|||
| \$ millions | |||||||||
| For the six-month period ended June 30, 2022 |
|||||||||
| Balance as of January 1, 2022 | 548 | 224 | (444) | 138 | (260) | 4,321 | 4,527 | 209 | 4,736 |
| Share-based compensation | - | 3 | - | 3 | - | - | 6 | - | 6 |
| Dividends | - | - | - | - | - | (476) | (476) | - | (476) |
| Comprehensive income | - | - | (124) | (25) | - | 1,245 | 1,096 | 34 | 1,130 |
| Balance as of June 30, 2022 | 548 | 227 | (568) | 116 | (260) | 5,090 | 5,153 | 243 | 5,396 |
| Attributable to the shareholders of the Company | Total equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Cumulative translation adjustments |
Capital reserves |
Treasury shares, at cost |
Retained earnings |
Total shareholders' equity |
|||
| \$ millions | |||||||||
| For the six-month period ended June 30, 2021 |
|||||||||
| Balance as of January 1, 2021 | 546 | 204 | (334) | 22 | (260) | 3,752 | 3,930 | 158 | 4,088 |
| Share-based compensation | 1 | 13 | - | (10) | - | - | 4 | - | 4 |
| Dividends | - | - | - | - | - | (101) | (101) | - | (101) |
| Comprehensive income | - | - | (21) | 99 | - | 290 | 368 | 20 | 388 |
| Balance as of June 30, 2021 | 547 | 217 | (355) | 111 | (260) | 3,941 | 4,201 | 178 | 4,379 |
The accompanying notes are an integral part of these condensed consolidated financial statements
| Non controlling interests |
Total equity |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Cumulative translation adjustments |
Capital reserves |
Treasury shares, at cost |
Retained earnings |
Total shareholders' equity |
|||
| \$ millions | |||||||||
| For the year ended December 31, 2021 |
|||||||||
| Balance as of January 1, 2021 | 546 | 204 | (334) | 22 | (260) | 3,752 | 3,930 | 158 | 4,088 |
| Share-based compensation | 2 | 20 | - | (16) | - | - | 6 | - | 6 |
| Dividends | - | - | - | - | - | (276) | (276) | (3) | (279) |
| Comprehensive income | - | - | (110) | 132 | - | 845 | 867 | 54 | 921 |
| Balance as of December 31, 2021 | 548 | 224 | (444) | 138 | (260) | 4,321 | 4,527 | 209 | 4,736 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
ICL Group Ltd. (hereinafter – the Company), is a company domiciled and incorporated in Israel. The Company's shares are traded on both the Tel-Aviv Stock Exchange (TASE) and the New York Stock Exchange (NYSE) under the ticker: ICL. The address of the Company's registered headquarters is 23 Aranha St., Tel Aviv, Israel. The Company is a subsidiary of Israel Corporation Ltd., a public company traded on the TASE under the ticker: ILCO:TA. The State of Israel holds a Special State Share in ICL and in some of its subsidiaries, entitling the State the right to safeguard the State of Israel vital interests.
The Company, together with its subsidiaries, associated companies and joint ventures (hereinafter - the Group or ICL), is a leading specialty minerals group that operates a unique, integrated business model. The Company competitively extracts certain minerals as raw materials and utilizes processing and product formulation technologies to add value to customers in two main end-markets: agriculture and Industrial (including food). ICL's products are used mainly in agriculture, electronics, food, fuel and gas exploration, water purification and desalination, construction, detergents, cosmetics, pharmaceuticals and automotive.
The Company's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board (IASB) and the Company uses IFRS as its generally accepted accounting principles ("GAAP").
The condensed consolidated interim financial statements were prepared in accordance with IAS 34, "Interim Financial Reporting" and do not include all the information required in complete, annual financial statements. These condensed consolidated interim financial statements and notes are unaudited and should be read together with the Company's audited financial statements included in its Annual Report on Form 20-F for the year ended December 31, 2021 (hereinafter – the Annual Financial Statements), as filed with the Securities and Exchange Commission ("SEC").
The accounting policies and assumptions used in preparation of these condensed consolidated interim financial statements are consistent with those used in preparation of the Company's Annual Financial Statements and in the Company's opinion, include all the adjustments necessary to fairly present such information. Interim results are not necessarily indicative of the Company's expected results for the entire year.
The Company made a number of insignificant classifications in comparative figures in order to adjust them to the manner of classification in the current financial statements. The said classifications have no effect on the total profit (loss).
ICL is a global specialty minerals company operating bromine, potash and phosphate mineral value chains in a unique, integrated business model. Our operations are organized under four segments: Industrial Products, Potash, Phosphate Solutions and Innovative Ag Solutions.
As the Company continues to focus on targeting long-term growth through its diversified specialty solutions, it decided to change its managerial structure so that, as of January 2022, the activities of ICL Boulby and other European business components were allocated from the potash and phosphate solutions segments, respectively, to the Innovative Ag Solutions segment. Comparative figures have been restated in order to reflect the structural change of the reportable segments.
Industrial Products – The Industrial Products segment produces bromine derived from a solution that is a by-product of the potash production process in Sodom, Israel, as well as bromine-based compounds. Industrial Products uses most of the bromine it produces for self-production of bromine compounds at its production sites in Israel, the Netherlands and China. In addition, the Industrial Products segment produces several grades of salt, magnesium chloride and some other specialty mineral products. Industrial Products is also engaged in the production and marketing of phosphorousbased flame retardants and additional phosphorus-based products.
Potash – The Potash segment produces and sells mainly potash, salt, magnesium and electricity. Potash is produced in Israel and Spain using an evaporation process to extract potash from the Dead Sea in Israel, and from conventional mining of an underground mine in Spain. The segment also includes production and sales of pure magnesium and magnesium alloys, as well as production and sales of chlorine and sylvinite. In addition, the segment sells salt products produced in its potash site in Spain. The Company operates a power plant in Sodom which supplies electricity to ICL companies in Israel (surplus electricity is sold to external customers) and steam to all facilities at the Sodom site.
Phosphate Solutions – The Phosphate Solutions segment is based on a phosphate value chain which uses phosphate commodity products, such as phosphate rock and fertilizergrade phosphoric acid ("green phosphoric acid"), to produce specialty products with higher added value. The segment also produces and markets phosphate-based fertilizers. Phosphate rock is mined and processed from open pit mines, three of which are located in the Negev Desert in Israel, while the fourth is situated in Yunnan province in China. Sulphuric acid, green phosphoric acid and phosphate fertilizers are also produced in the facilities in Israel and China.
The Phosphate Solutions segment manufactures pure phosphoric acid by purifying green phosphoric acid. Pure phosphoric acid and green phosphoric acid are used to manufacture downstream products with high added value, such as phosphate salts and acids, for a wide range of food and industrial applications. Phosphate salts and acids are used in various industrial end markets, such as oral care, cleaning products, paints and coatings, water treatment, asphalt modification, construction, metal treatment and more. The segment's products for the food industry include functional food ingredients and phosphate additives, which provide texture and stability solutions for processed meat, meat alternatives, poultry, seafood, dairy, beverage and baked goods. In addition, the segment supplies pure phosphoric acid to ICL's specialty fertilizers business and produces organic milk components and whey proteins for the food ingredients industry.
Innovative Ag Solutions – The Innovative Ag Solutions segment aims to achieve global leadership in specialty fertilizers markets by enhancing its global positions in its core markets of specialty agriculture, ornamental horticulture, turf and landscaping, targeting high-growth markets such as Brazil, India and China, by leveraging its unique R&D capabilities, vast agronomic experience, global footprint, backward integration to potash, phosphate and polysulphate and chemistry know-how, while integrating and generating synergies from acquired businesses.
ICL is continuously working to expand its broad portfolio of specialty plant nutrition, plant stimulation and plant health solutions, which consists of enhanced efficiency and controlled release fertilizers (CRF), organic fertilizers, water soluble fertilizers (WSF), liquid fertilizers and straights (MKP/MAP/PeKacid), soil and foliar micronutrients, secondary nutrients, biostimulants, soil conditioners, seed treatment products, and adjuvants.
The Innovative Ag Solutions segment develops, manufactures, markets and sells its products globally, mainly in South America, Europe, Asia, North America and Israel. It produces water soluble specialty fertilizers in Belgium, Israel and Spain, organic, ornamental horticulture, turf and landscaping products in the UK and the Netherlands, liquid fertilizers in Israel, Spain and China, straights soluble fertilizers in China and Israel, controlled-release fertilizers in the Netherlands, Brazil and the United States, as well as secondary nutrients, biostimulants, soil conditioners, seed treatment products, and adjuvants in Brazil.
Other Activities – Business activities include, among other things, ICL's innovative arm, promoting innovation, developing new products and services, as well as digital platforms and technological solutions for farmers and agronomists. This category includes Growers and Agmatix, innovative start-ups that are developing agricultural data processing and analysis capabilities for the future of agriculture. These activities are not presented as reportable segments as they do not meet required quantitative thresholds.
Capital investments made by the segments for each of the reporting periods include mainly property, plant and equipment as well as intangible assets acquired in the ordinary course of business and as part of business combinations.
Segment revenue, expenses and results include inter-segment transfers, which are based on transactions prices in the ordinary course of business. This is aligned with reports that are regularly reviewed by the Chief Operating Decision Maker. Inter-segment transfers are eliminated as part of the financial statements' consolidation process.
| Industrial Products | Potash | Phosphate Solutions |
Innovative Ag Solutions |
Other Activities |
Reconciliations | Consolidated | |
|---|---|---|---|---|---|---|---|
| \$ millions | |||||||
| For the three-month period ended June 30, 2022 |
|||||||
| Sales to external parties | 478 | 877 | 832 | 689 | 4 | - | 2,880 |
| Inter-segment sales | 8 | 74 | 83 | 11 | 1 | (177) | - |
| Total sales | 486 | 951 | 915 | 700 | 5 | (177) | 2,880 |
| Segment operating income (loss) | 191 | 576 | 268 | 141 | (1) | (36) | 1,139 |
| Other income not allocated to the segments | - | ||||||
| Operating income | 1,139 | ||||||
| Financing expenses, net | (14) | ||||||
| Income before income taxes | 1,125 | ||||||
| Depreciation and amortization | 15 | 40 | 47 | 14 | - | 3 | 119 |
| Capital expenditures | 18 | 113 | 60 | 21 | 3 | 2 | 217 |
| Industrial Products | Potash | Phosphate Solutions |
Innovative Ag Solutions |
Other Activities |
Reconciliations | Consolidated | |
|---|---|---|---|---|---|---|---|
| \$ millions | |||||||
| For the three-month period ended June 30, 2021 |
|||||||
| Sales to external parties | 406 | 334 | 539 | 331 | 7 | - | 1,617 |
| Inter-segment sales | 4 | 46 | 43 | 3 | - | (96) | - |
| Total sales | 410 | 380 | 582 | 334 | 7 | (96) | 1,617 |
| Segment profit (loss) Other expenses not allocated to the segments Operating income |
114 | 42 | 77 | 21 | (2) | (16) | 236 7 243 |
| Financing expenses, net | (30) | ||||||
| Share in earnings of equity-accounted investees | 1 | ||||||
| Income before income taxes | 214 | ||||||
| Depreciation, amortization and impairment | 14 | 38 | 56 | 13 | 1 | (7) | 115 |
| Capital expenditures | 14 | 68 | 67 | 10 | 2 | 3 | 164 |
| Industrial Products | Potash | Phosphate Solutions |
Innovative Ag Solutions |
Other Activities |
Reconciliations | Consolidated | |
|---|---|---|---|---|---|---|---|
| \$ millions | |||||||
| For the six-month period ended June 30, 2022 |
|||||||
| Sales to external parties | 966 | 1,605 | 1,580 | 1,245 | 9 | - | 5,405 |
| Inter-segment sales | 14 | 141 | 133 | 21 | 2 | (311) | - |
| Total sales | 980 | 1,746 | 1,713 | 1,266 | 11 | (311) | 5,405 |
| Segment operating income (loss) | 379 | 986 | 468 | 234 | (4) | (44) | 2,019 |
| Other income not allocated to the segments | 22 | ||||||
| Operating income | 2,041 | ||||||
| Financing expenses, net | (48) | ||||||
| Income before income taxes | 1,993 | ||||||
| Depreciation and amortization | 30 | 80 | 94 | 31 | 1 | 5 | 241 |
| Capital expenditures | 40 | 175 | 109 | 38 | 4 | 4 | 370 |
| Industrial Products | Potash | Phosphate Solutions |
Innovative Ag Solutions |
Other Activities |
Reconciliations | Consolidated | |
|---|---|---|---|---|---|---|---|
| \$ millions | |||||||
| For the six-month period ended June 30, 2021 |
|||||||
| Sales to external parties | 800 | 639 | 1,006 | 668 | 14 | - | 3,127 |
| Inter-segment sales | 8 | 90 | 78 | 6 | 1 | (183) | - |
| Total sales | 808 | 729 | 1,084 | 674 | 15 | (183) | 3,127 |
| Segment profit (loss) | 219 | 71 | 119 | 41 | (4) | (25) | 421 |
| Other expenses not allocated to the segments | 7 | ||||||
| Operating income | 428 | ||||||
| Financing expenses, net | (50) | ||||||
| Share in earnings of equity-accounted investees | 1 | ||||||
| Income before income taxes | 379 | ||||||
| Depreciation, amortization and impairment | 31 | 71 | 108 | 26 | 1 | (5) | 232 |
| Capital expenditures | 31 | 127 | 115 | 23 | 3 | 6 | 305 |
| Capital expenditures as part of business combination |
- | - | - | 70 | - | - | 70 |
| Industrial Products | Potash | Phosphate Solutions |
Innovative Ag Solutions |
Other Activities |
Reconciliations | Consolidated | |
|---|---|---|---|---|---|---|---|
| \$ millions | |||||||
| For the year ended December 31, 2021 | |||||||
| Sales to external parties | 1,601 | 1,598 | 2,087 | 1,644 | 25 | - | 6,955 |
| Inter-segment sales | 16 | 178 | 167 | 26 | 3 | (390) | - |
| Total sales | 1,617 | 1,776 | 2,254 | 1,670 | 28 | (390) | 6,955 |
| Segment operating income (loss) | 435 | 399 | 294 | 135 | (8) | (61) | 1,194 |
| Other income not allocated to the segments | 16 | ||||||
| Operating income | 1,210 | ||||||
| Financing expenses, net | (122) | ||||||
| Share in earnings of equity-accounted investees | 4 | ||||||
| Income before income taxes | 1,092 | ||||||
| Depreciation amortization and impairment | 65 | 148 | 207 | 62 | 2 | - | 484 |
| Capital expenditures | 74 | 270 | 228 | 74 | 6 | 17 | 669 |
| Capital expenditures as part of business combination |
- | - | - | 377 | - | - | 377 |
The following table presents the distribution of the operating segments sales by geographical location of the customer:
| 4-6/2022 | 4-6/2021 | 1-6/2022 | 1-6/2021 | 1-12/2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| \$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
\$ millions |
% of sales |
||
| Brazil | 797 | 28 | 230 | 14 | 1,287 | 24 | 316 | 10 | 1,178 | 17 | |
| China | 421 | 15 | 255 | 16 | 870 | 16 | 500 | 16 | 1,060 | 15 | |
| USA | 326 | 11 | 245 | 15 | 706 | 13 | 520 | 17 | 1,091 | 16 | |
| United Kingdom | 127 | 4 | 88 | 5 | 246 | 5 | 215 | 7 | 386 | 6 | |
| India | 107 | 4 | 61 | 4 | 184 | 3 | 86 | 3 | 213 | 3 | |
| Germany | 106 | 4 | 94 | 6 | 220 | 4 | 189 | 6 | 345 | 5 | |
| Spain | 101 | 4 | 66 | 4 | 196 | 4 | 148 | 5 | 280 | 4 | |
| Israel | 98 | 3 | 75 | 5 | 181 | 3 | 138 | 4 | 291 | 4 | |
| Netherlands | 92 | 3 | 29 | 2 | 153 | 3 | 62 | 2 | 127 | 2 | |
| France | 89 | 3 | 67 | 4 | 167 | 3 | 141 | 5 | 270 | 4 | |
| All other | 616 | 21 | 407 | 25 | 1,195 | 22 | 812 | 25 | 1,714 | 24 | |
| Total | 2,880 | 100 | 1,617 | 100 | 5,405 | 100 | 3,127 | 100 | 6,955 | 100 |
The following tables present the distribution of the operating segments sales by geographical location of the customer:
| Industrial Products |
Potash | Phosphate Solutions |
Innovative Ag Solutions |
Other Activities |
Reconciliations | Consolidated | |
|---|---|---|---|---|---|---|---|
| \$ millions | |||||||
| For the three-month period ended June 30, 2022 | |||||||
| South America | 9 | 412 | 180 | 243 | - | (16) | 828 |
| Europe | 149 | 211 | 259 | 241 | 4 | (58) | 806 |
| Asia | 189 | 206 | 250 | 97 | - | (13) | 729 |
| North America | 114 | 41 | 155 | 50 | 1 | (2) | 359 |
| Rest of the world | 25 | 81 | 71 | 69 | - | (88) | 158 |
| Total | 486 | 951 | 915 | 700 | 5 | (177) | 2,880 |
| Industrial Products |
Potash | Phosphate Solutions |
Innovative Ag Solutions |
Other Activities |
Reconciliations | Consolidated | |
|---|---|---|---|---|---|---|---|
| \$ millions | |||||||
| For the three-month period ended June 30, 2021 | |||||||
| South America | 22 | 104 | 106 | 31 | - | (1) | 262 |
| Europe | 142 | 86 | 155 | 173 | 6 | (43) | 519 |
| Asia | 148 | 117 | 150 | 54 | - | (7) | 462 |
| North America | 87 | 30 | 125 | 30 | - | (1) | 271 |
| Rest of the world | 11 | 43 | 46 | 46 | 1 | (44) | 103 |
| Total | 410 | 380 | 582 | 334 | 7 | (96) | 1,617 |
The following tables present the distribution of the operating segments sales by geographical location of the customer:
| Industrial Products |
Potash | Phosphate Solutions |
Innovative Ag Solutions |
Other Activities |
Reconciliations | Consolidated | |
|---|---|---|---|---|---|---|---|
| \$ millions | |||||||
| For the six-month period ended June 30, 2022 | |||||||
| South America | 20 | 656 | 297 | 389 | - | (18) | 1,344 |
| Europe | 305 | 360 | 471 | 492 | 9 | (107) | 1,530 |
| Asia | 400 | 438 | 489 | 163 | - | (24) | 1,466 |
| North America | 211 | 141 | 325 | 99 | 1 | (3) | 774 |
| Rest of the world | 44 | 151 | 131 | 123 | 1 | (159) | 291 |
| Total | 980 | 1,746 | 1,713 | 1,266 | 11 | (311) | 5,405 |
| Industrial Products |
Potash | Phosphate Solutions |
Innovative Ag Solutions |
Other Activities |
Reconciliations | Consolidated | |
|---|---|---|---|---|---|---|---|
| \$ millions | |||||||
| For the six-month period ended June 30, 2021 | |||||||
| South America | 35 | 128 | 164 | 45 | - | (1) | 371 |
| Europe | 286 | 241 | 301 | 388 | 13 | (82) | 1,147 |
| Asia | 278 | 187 | 290 | 102 | - | (11) | 846 |
| North America | 182 | 86 | 239 | 62 | 1 | (4) | 566 |
| Rest of the world | 27 | 87 | 90 | 77 | 1 | (85) | 197 |
| Total | 808 | 729 | 1,084 | 674 | 15 | (183) | 3,127 |
The following table presents the distribution of the operating segments sales by geographical location of the customer:
| Industrial Products |
Potash | Phosphate Solutions |
Innovative Ag Solutions |
Other Activities |
Reconciliations | Consolidated | |
|---|---|---|---|---|---|---|---|
| \$ millions | |||||||
| For the year ended December 31, 2021 | |||||||
| South America | 64 | 467 | 343 | 436 | - | (5) | 1,305 |
| Europe | 530 | 430 | 611 | 727 | 23 | (162) | 2,159 |
| Asia | 597 | 478 | 617 | 206 | 1 | (23) | 1,876 |
| North America | 363 | 209 | 491 | 127 | 1 | (5) | 1,186 |
| Rest of the world | 63 | 192 | 192 | 174 | 3 | (195) | 429 |
| Total | 1,617 | 1,776 | 2,254 | 1,670 | 28 | (390) | 6,955 |
The carrying amounts in the financial statements of certain financial assets and financial liabilities, including cash and cash equivalents, investments, short-term deposits and loans, receivables and other debit balances, long-term investments and receivables, short-term credit, payables and other credit balances, long-term loans bearing variable interest and other liabilities, and derivative financial instruments, correspond to or approximate their fair value.
The following table details the carrying amount and fair value of financial instrument groups presented in the financial statements not in accordance with their fair value:
| June 30, 2022 | June 30, 2021 | December 31, 2021 | |||||
|---|---|---|---|---|---|---|---|
| Carrying amount | Fair value | Carrying amount | Fair value | Carrying amount | Fair value | ||
| \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | \$ millions | ||
| Loans bearing fixed interest | 343 | 327 | 106 | 112 | 407 | 408 | |
| Debentures bearing fixed interest | |||||||
| Marketable | 1,341 | 1,292 | 1,495 | 1,713 | 1,524 | 1,730 | |
| Non-marketable | 196 | 198 | 196 | 210 | 195 | 208 | |
| 1,880 | 1,817 | 1,797 | 2,035 | 2,126 | 2,346 |
The following table presents an analysis of the financial instruments measured by fair value, using the valuation method.
The following levels were defined:
Level 1: Quoted (unadjusted) prices in an active market for identical instruments
Level 2: Observed data (directly or indirectly) not included in Level 1 above.
| Level 1 | June 30, 2022 |
June 30, 2021 |
December 31, 2021 |
|
|---|---|---|---|---|
| \$ millions | \$ millions | \$ millions | ||
| Investments at fair value through other comprehensive income | - | 180 - |
| Level 2 | June 30, 2022 |
June 30, 2021 |
December 31, 2021 \$ millions |
|
|---|---|---|---|---|
| \$ millions | \$ millions | |||
| Derivatives designated as economic hedge, net | (27) | (3) | 15 | |
| Derivatives designated as cash flow hedge, net | (1) | 77 | 120 | |
| (28) | 74 | 135 |
The Company is exposed to changes in the exchange rate of the shekel against the dollar in respect of principal and interest in certain debentures, loans, labor costs and other operating expenses. The Company's risk management strategy is to hedge the changes in cash flows deriving from liabilities, labor costs and other operational costs denominated in shekels by using derivatives. These exposures are hedged from time to time, according to the assessment of the exposure and inherent risks against which the Company elects to hedge, in accordance with the Company's risk management strategy.
| Decision date for dividend distribution by the Board of Directors | Actual date of dividend distribution | Distributed amount (\$ millions) |
Dividend per share (\$) |
|---|---|---|---|
| February 8, 2022 | March 8, 2022 | 169 | 0.13 |
| May 10, 2022 | June 15, 2022 | 307 | 0.24 |
| July 26, 2022 * | September 14, 2022 | 375 | 0.29 |
* The dividend will be distributed on September 14, 2022, with a record date for eligibility of August 31, 2022.
In the second quarter of 2022, the Company recorded tax expenses for prior years in the amount of \$188 million, including interest and linkage and net of corporate income tax, of which \$124 million was in connection with the understandings reached regarding the measurement of fixed assets in the said final assessments (for 2016-2020).
In the event of difficulties in the implementation of the Company's actions, including due to objections by the authorities and/or a delay in obtaining the required permits and approvals, the operational continuity of P-9 may be impaired, which may lead also to a significant decline in the water level of Pond 5, which also serves as a beach for tourism purposes, and accordingly, may materially adversely affect the continued operations of the Company and its business and financial results. Considering the preliminary stage of the process and uncertainty relating to the final restoration plans to be determined by the relevant authorities, it is a difficult to estimate its outcome. Nevertheless, as of the reporting date, in the Company's estimation, no material impact on the Company's financial statements is expected.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
By: /s/ Aviram Lahav
Name: Aviram Lahav Title: Chief Financial Officer
By: /s/ Aya Landman
Name: Aya Landman
Title: VP, Company Secretary & Global Compliance
Date: July 27, 2022
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.